Citation Impact
Citing Papers
Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
2013
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow
2017 StandoutNobel
Wnt signaling during fracture repair
2009
MicroRNA: A new player in stem cells
2006
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
2005
Fracture healing: mechanisms and interventions
2014 Standout
Safety and Tolerability of Human Placenta-Derived Cells (PDA001) in Treatment-Resistant Crohn’s Disease
2013
Radiation injury and the protein C pathway
2004
Treatment approaches to IgG4-related systemic disease
2010
Building bone to reverse osteoporosis and repair fractures
2008
Cancer to bone: a fatal attraction
2011 Standout
Emerging therapeutic opportunities for skeletal restoration
2011
Wnt signaling in cancer
2016 Standout
Targeting the Wnt/β-Catenin Pathway to Regulate Bone Formation in the Adult Skeleton
2007
The role of magnesium ions in bone regeneration involves the canonical Wnt signaling pathway
2019 Standout
Stem Cell Therapies in Clinical Trials: Progress and Challenges
2015 Standout
Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma
2007
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
2014
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6
2008
Pathogenesis of myeloma bone disease
2008
A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
2011
Prevention of VTE in Nonsurgical Patients
2012 Standout
Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis
2006
Osteoporosis: now and the future
2011 Standout
Dickkopf-1: a suitable target for the management of myeloma bone disease
2009
Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells
2009
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Wnt/β-Catenin Signaling and Disease
2012 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Simvastatin Ameliorates Radiation Enteropathy Development After Localized, Fractionated Irradiation by a Protein C-Independent Mechanism
2007
Wnt signaling as a therapeutic target for bone diseases
2009
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network
2009
R‐spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway
2010
Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
2010
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
2012 Standout
What old means to bone
2010 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
2007
The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis
2011
microRNAs as oncogenes and tumor suppressors
2006 Standout
IgG4-related disease
2014 Standout
Modulation of Wnt signaling influences fracture repair
2010
Bone metastasis: the importance of the neighbourhood
2016
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis
2012 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway
2018
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
2010
The role of the Wnt signaling pathway in osteoblast commitment and differentiation
2007
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
2007 Standout
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy
2005
Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy
2007
Hypoxia-inducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype
2014 StandoutNobel
The role of Dickkopf-1 in bone development, homeostasis, and disease
2008
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
2009
Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases
2012
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor Cytotoxicity
2017 StandoutNobel
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
2014 Standout
Magnetic Nanoparticles
2012
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Targeting the bone marrow microenvironment in multiple myeloma
2014
Lrp6 Hypomorphic Mutation Affects Bone Mass Through Bone Resorption in Mice and Impairs Interaction With Mesd
2008 StandoutNobel
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2009
Statins and Blood Coagulation
2004
Role of Hypoxia-Inducible Factors in Breast Cancer Metastasis
2013 StandoutNobel
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
2008
Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1
2016 StandoutNobel
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
2005
R-Spondin Family Members Regulate the Wnt Pathway by a Common Mechanism
2008
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Multiple Myeloma
2011 Standout
Pravastatin Inhibits the Rho/CCN2/Extracellular Matrix Cascade in Human Fibrosis Explants and Improves Radiation-Induced Intestinal Fibrosis in Rats
2007
Mechanisms of Nucleation and Growth of Nanoparticles in Solution
2014 Standout
Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment
2007
Works of Wen Ling being referenced
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation
2003
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo
2008
Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
2006
Systemically Transplanted Human Bone Marrow Mesenchymal Stem Cells Primarily Traffic to Mesenteric Lymph Nodes
2010
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
2006
Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
2010
Inhibition of DKK1 Activity Is Associated with Increased Osteoblast Numbers and Bone Formation, Reduced Osteoclast Activity and Inhibition of Tumor Growth in the SCID-rab Model for Primary Myeloma.
2005